John S. Bomalaski

6.9k total citations
132 papers, 4.8k citations indexed

About

John S. Bomalaski is a scholar working on Biotechnology, Genetics and Molecular Biology. According to data from OpenAlex, John S. Bomalaski has authored 132 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Biotechnology, 43 papers in Genetics and 33 papers in Molecular Biology. Recurrent topics in John S. Bomalaski's work include Cancer Research and Treatments (72 papers), Virus-based gene therapy research (35 papers) and Neuroblastoma Research and Treatments (22 papers). John S. Bomalaski is often cited by papers focused on Cancer Research and Treatments (72 papers), Virus-based gene therapy research (35 papers) and Neuroblastoma Research and Treatments (22 papers). John S. Bomalaski collaborates with scholars based in United States, United Kingdom and Taiwan. John S. Bomalaski's co-authors include Mike A. Clark, Frederick W. Holtsberg, Mark Ensor, M A Clark, Stanley T. Crooke, Steven A. Curley, Robert B. Zurier, Marion R. Steiner, Peter W. Szlosarek and Achim A. Jungbluth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

John S. Bomalaski

129 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Bomalaski United States 37 1.8k 1.8k 1.3k 1.1k 582 132 4.8k
Sundaram Ramakrishnan United States 37 532 0.3× 2.9k 1.6× 1.0k 0.8× 275 0.3× 1.1k 1.8× 128 4.9k
Jean‐François Beaulieu Canada 47 193 0.1× 3.2k 1.8× 708 0.5× 1.5k 1.4× 1.7k 2.9× 196 7.0k
Masayoshi Namba Japan 35 267 0.1× 2.8k 1.6× 533 0.4× 594 0.6× 1.1k 2.0× 186 4.8k
Shingo Tsuji Japan 39 151 0.1× 2.4k 1.3× 779 0.6× 1.4k 1.3× 920 1.6× 154 6.9k
Dhananjaya V. Kalvakolanu United States 44 249 0.1× 3.1k 1.7× 813 0.6× 526 0.5× 1.7k 2.9× 114 5.5k
Ryoichi Oyasu United States 38 218 0.1× 2.2k 1.3× 976 0.7× 310 0.3× 1.3k 2.2× 163 5.1k
Kazuyoshi Yanagihara Japan 49 306 0.2× 5.0k 2.8× 1.7k 1.3× 668 0.6× 2.2k 3.8× 215 7.8k
Paola Rizzo Italy 41 297 0.2× 2.7k 1.5× 720 0.5× 479 0.4× 2.0k 3.5× 121 6.1k
C D Bucana United States 40 321 0.2× 2.7k 1.5× 1.2k 0.9× 276 0.3× 2.0k 3.5× 81 5.7k
Guojun Wu China 38 213 0.1× 2.5k 1.4× 761 0.6× 306 0.3× 1.2k 2.1× 102 4.1k

Countries citing papers authored by John S. Bomalaski

Since Specialization
Citations

This map shows the geographic impact of John S. Bomalaski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Bomalaski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Bomalaski more than expected).

Fields of papers citing papers by John S. Bomalaski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Bomalaski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Bomalaski. The network helps show where John S. Bomalaski may publish in the future.

Co-authorship network of co-authors of John S. Bomalaski

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Bomalaski. A scholar is included among the top collaborators of John S. Bomalaski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Bomalaski. John S. Bomalaski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Zhimin Xu, Modesto Rojas, et al.. (2024). Arginine deprivation/citrulline augmentation with ADI-PEG20 as novel therapy for complications in type 2 diabetes. Molecular Metabolism. 89. 102020–102020. 1 indexed citations
2.
3.
Kremer, Jeff C., Zongtao Lin, Zhixian Hu, et al.. (2023). Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment. Clinical Cancer Research. 29(16). 3189–3202. 10 indexed citations
4.
Phillips, Melissa, Michael D. Allen, Essam Ghazaly, et al.. (2023). A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma. Pharmacological Reports. 75(3). 570–584. 4 indexed citations
5.
Kraehenbuehl, Lukas, Aliya Holland, Levi Mangarin, et al.. (2022). Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma. Cancers. 14(11). 2638–2638. 15 indexed citations
6.
Yao, Shuyang, Filip Jankú, Kimberly B. Koenig, et al.. (2021). Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors. Cancer Medicine. 11(2). 340–347. 21 indexed citations
7.
Halim, Leena, Farideh Miraki‐Moud, David Taussig, et al.. (2021). Priming Death Receptor Mediated Apoptosis with Arginine Starvation Sensitises Arginine Auxotrophic B-ALL to CAR-T. Blood. 138(Supplement 1). 2787–2787.
8.
Szlosarek, Peter W., Akhila Wimalasingham, Melissa Phillips, et al.. (2021). Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. Cancer Medicine. 10(19). 6642–6652. 14 indexed citations
9.
Singh, Pankaj K., Amit Deorukhkar, Bhanu Prasad Venkatesulu, et al.. (2019). Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation. Molecular Cancer Therapeutics. 18(12). 2381–2393. 28 indexed citations
10.
Tsai, Hui‐Jen, Shih Sheng Jiang, Wen-Chun Hung, et al.. (2017). A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients. Scientific Reports. 7(1). 11253–11253. 61 indexed citations
11.
12.
Tomlinson, Benjamin, James A. Thomson, John S. Bomalaski, et al.. (2015). Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors. Clinical Cancer Research. 21(11). 2480–2486. 66 indexed citations
13.
Stelter, Lars, Michael J. Evans, Achim A. Jungbluth, et al.. (2012). Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma. Journal of Nuclear Medicine. 53(2). 281–286. 14 indexed citations
14.
Kelly, Marcus P., et al.. (2011). Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. British Journal of Cancer. 106(2). 324–332. 98 indexed citations
15.
Petrović, Nenad, Darryl A. Knight, John S. Bomalaski, Philip J. Thompson, & Neil L.A. Misso. (2006). Concomitant activation of extracellular signal-regulated kinase and induction of COX-2 stimulates maximum prostaglandin E2 synthesis in human airway epithelial cells. Prostaglandins & Other Lipid Mediators. 81(3-4). 126–135. 12 indexed citations
16.
17.
Ostrov, Barbara E., Antonio J. Reginato, Daniel G. Baker, et al.. (1996). Clinical Assessment of the 1987 American College of Rheumatology Criteria for Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 25(5). 277–281. 34 indexed citations
18.
Goddard, David H., John S. Bomalaski, Stanley Lipper, Robert Shorr, & Mike A. Clark. (1996). Phospholipase A2-mediated inflammation induces regression of malignant gliomas. Cancer Letters. 102(1-2). 1–6. 14 indexed citations
19.
Bomalaski, John S., et al.. (1992). Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.. Obstetrics and Gynecology. 79(1). 95–100. 49 indexed citations
20.
Hartz, Reneé S., John S. Bomalaski, Joseph LoCicero, & Robert L. Murphy. (1984). Pleural ascites without abdominal fluid: Surgical considerations. Journal of Thoracic and Cardiovascular Surgery. 87(1). 141–143. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sundaram Ramakrishnan Breakdown of academic impact, for papers by Jean‐François Beaulieu Breakdown of academic impact, for papers by Masayoshi Namba Breakdown of academic impact, for papers by Shingo Tsuji Breakdown of academic impact, for papers by Dhananjaya V. Kalvakolanu Breakdown of academic impact, for papers by Ryoichi Oyasu Breakdown of academic impact, for papers by Kazuyoshi Yanagihara Breakdown of academic impact, for papers by Paola Rizzo Breakdown of academic impact, for papers by C D Bucana Breakdown of academic impact, for papers by Guojun Wu
Rankless by CCL
2026